NCT04015843 is a clinical trial in Hypertension, sponsored by China Cardiovascular Association.

Who is sponsoring NCT04015843?

NCT04015843 is sponsored by China Cardiovascular Association.

What condition does NCT04015843 study?

NCT04015843 studies Hypertension.

Is NCT04015843 still recruiting?

NCT04015843 is currently status unknown. Last updated 25 November 2019.

Last reviewed 2019-11-25 · How we verify

NCT04015843

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compliance of Blood Pressure and Lipid in Hypertensive Patients Under the Management of Hospitals at Different Levels

Status unknown Last updated 25 November 2019

What this trial tests

trial in Hypertension in 1,800 participants. Status unknown.

Timeline

22 August 2019

Primary endpoint
30 August 2020

30 November 2020

Quick facts

Lead sponsor	China Cardiovascular Association
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,800
Start date	22 August 2019
Primary completion	30 August 2020
Estimated completion	30 November 2020
Sites	1 location across China

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

China Cardiovascular Association

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center, prospective cohort study that collects only diagnostic and therapeutic data in subjects but does not interfere with treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other China Cardiovascular Association trials

Trials by the same sponsor.

NCT03931200 — Demographic and Clinical Characteristics, Treatment Patterns and Clinical Outcomes of Heart Failure Patients in China · completed
NCT03691246 — Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China · unknown
NCT03398954 — a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04015843 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China Cardiovascular Association
Last refreshed: 25 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04015843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing